In re Jiangbo Pharmaceuticals, Inc.
District Court, S.D. Florida
1Opinion of the Court
*1248 OMNIBUS ORDER ON DEFENDANTS’ MOTIONS TO DISMISS
MARCIA G. COOKE, District Judge.
THIS MATTER is before me on Defendant Elsa Sung’s Motion to Dismiss (ECF No. 51) and Defendant Frazer, LLP’s Motion to Dismiss (ECF No. 63). I have reviewed the arguments, the record, and the relevant legal authorities. For the reasons provided, the Motions are granted.
I. Background
Lead Plaintiffs, Christopher Brody and Tara Lewis, bring this federal securities class action on behalf of themselves and a putative class of all persons or entities (collectively, “Plaintiffs”) who purchased or acquired Jiangbo…
2Cases cited42 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Conley v. GibsonSupreme Court of the United States · 1957
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Dura Pharmaceuticals, Inc. v. BroudoSupreme Court of the United States · 2005
37 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Christopher Brophy v. Jiangbo Pharmaceuticals, Inc.Court of Appeals for the Eleventh Circuit · 2015
- Porter v. GrafTech International Ltd.District Court, N.D. Ohio · 2025
- Stein v. Aarons, Inc.District Court, N.D. Georgia · 2022